Galectin Therapeutics
- Pharmaceutical Preparations
- Norcross, Georgia
Compensation history
Top executives at Galectin Therapeutics received an average of $735K per person in annual compensation from 2006 to 2023.
Average pay of disclosed executives at Galectin Therapeutics
By year
Executives
We found 12 executives who work or worked at Galectin Therapeutics.
Joel Lewis
Galectin Therapeutics
Chief Executive Officer
Pol Boudes
Galectin Therapeutics
Chief Medical Officer
Jack Callicutt
Galectin Therapeutics
Chief Financial Officer
Harold Shlevin
Galectin Therapeutics
Chief Executive Officer
Peter Traber
Galectin Therapeutics
Chief Executive Officer
James Czirr
Galectin Therapeutics
Chairman
Maureen Foley
Galectin Therapeutics
Chief Operating Officer
Theodore Zucconi
Galectin Therapeutics
Chief Executive Officer
News
Galectin Therapeutics CEO Joel Lewis' 2023 pay slips 1% to $964K
December 3, 2024
Galectin Therapeutics CEO Joel Lewis' 2022 pay slips 17% to $974K
October 6, 2023
Galectin Therapeutics CEO Joel Lewis' 2021 pay jumps 55% to $1.2M
October 17, 2022
Galectin Therapeutics CEO Harold Shlevin's 2019 pay falls 25% to $1.3M
October 19, 2020
About Galectin Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address4960 Peachtree Industrial Boulevard, Suite 240, Norcross, Georgia 30071
- Phone678-620-3186
- Fiscal year endDecember 31
- Former names
- PRO PHARMACEUTICALS INCUntil May 25, 2011
Source: SEC filings on December 3, 2024, October 6, 2023, October 17, 2022, October 19, 2020, April 11, 2018, November 7, 2017, November 10, 2016, April 12, 2013, April 11, 2011, March 26, 2010, and April 16, 2008.